Off Patent
August 2027

Azilect

rasagiline mesylate

Teva Neuroscience Inc

Tablet (oral) · NDA 021641

Last listed protection ends
August 27, 2027

The FDA lists 2 patents for Azilect, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 7,572,834
    Claims the drug product
  2. Patent 7,815,942
    Claims the drug substance, the drug product and a use (U-219)